{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:17:49Z","timestamp":1783696669695,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jinhua Science and Technology Program","award":["NO. 2022-3-068"],"award-info":[{"award-number":["NO. 2022-3-068"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s43441-026-00968-2","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T16:34:49Z","timestamp":1777048489000},"page":"1112-1123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adverse Events Associated with Clascoterone: A Real-World Pharmacovigilance Study of the Food and Drug Administration Adverse Event Reporting System"],"prefix":"10.1007","volume":"60","author":[{"given":"Li","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6716-4451","authenticated-orcid":false,"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"968_CR1","first-page":"13","volume":"7","author":"DD Lynn","year":"2016","unstructured":"Lynn DD, Umari T, Dunnick CA, et al. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther. 2016;7:13\u201325.","journal-title":"Adolesc Health Med Ther"},{"issue":"3","key":"968_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40257-019-00423-z","volume":"20","author":"SS Kolli","year":"2019","unstructured":"Kolli SS, Pecone D, Pona A, et al. Topical retinoids in acne vulgaris: a systematic review. Am J Clin Dermatol. 2019;20(3):345\u201365.","journal-title":"Am J Clin Dermatol"},{"key":"968_CR3","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1542\/peds.2019-2056L","volume":"145","author":"KA Habeshian","year":"2020","unstructured":"Habeshian KA, Cohen BA. Current issues in the treatment of acne vulgaris. pediatrics. 2020;145:S225\u201330.","journal-title":"Pediatrics"},{"issue":"4","key":"968_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/14740338.2020.1757646","volume":"19","author":"A Otlewska","year":"2020","unstructured":"Otlewska A, Baran W, Batycka-Baran A. Adverse events related to topical drug treatments for acne vulgaris. Expert Opin Drug Saf. 2020;19(4):513\u201321.","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"968_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40257-021-00666-9","volume":"23","author":"L Drake","year":"2022","unstructured":"Drake L, Reyes-Hadsall S, Barbieri JS, et al. New developments in topical acne therapy. Am J Clin Dermatol. 2022;23(2):125\u201336.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"968_CR6","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.jaad.2024.09.015","volume":"91","author":"FE Fonjungo","year":"2024","unstructured":"Fonjungo FE, Barnes LA, Aleshin MA. Antibiotic, hormonal\/metabolic, and retinoid therapies for hidradenitis suppurativa. J Am Acad Dermatol. 2024;91(6):S37\u201341.","journal-title":"J Am Acad Dermatol"},{"key":"968_CR7","first-page":"00368","volume":"25","author":"W Nie","year":"2025","unstructured":"Nie W, Wu X, Xia Y, et al. Reported psychiatric adverse events among isotretinoin users: monitoring priorities from a 20-year FDA adverse event reporting system database study. J Am Acad Dermatol. 2025;25:00368\u201300368.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"968_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41569-024-01097-9","volume":"22","author":"JM Gelfand","year":"2025","unstructured":"Gelfand JM, Song WB, Langan SM, et al. Cardiodermatology: the heart of the connection between the skin and cardiovascular disease. Nat Rev Cardiol. 2025;22(5):354\u201371.","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"968_CR9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jaad.2022.04.021","volume":"90","author":"T Jennings","year":"2024","unstructured":"Jennings T, Duffy R, McLarney M, et al. Acne scarring d pathophysiology, diagnosis, prevention and education: part I. J Am Acad Dermatol. 2024;90(6):1123\u201334.","journal-title":"J Am Acad Dermatol"},{"key":"968_CR10","doi-asserted-by":"crossref","unstructured":"Dhillon S, Clascoterone. First Approval Drugs. 2020;80(16):1745\u201350.","DOI":"10.1007\/s40265-020-01417-6"},{"issue":"2","key":"968_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jaad.2020.04.087","volume":"83","author":"L Eichenfield","year":"2020","unstructured":"Eichenfield L, Hebert A, Gold LS, et al. Open-label, long-term extension study to evaluate the safety of clascoterone (CB-03-01) cream, 1% twice daily, in patients with acne vulgaris. J Am Acad Dermatol. 2020;83(2):477\u201385.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"968_CR12","doi-asserted-by":"publisher","first-page":"1006.e1001","DOI":"10.1016\/j.jaad.2023.12.017","volume":"90","author":"RV Reynolds","year":"2024","unstructured":"Reynolds RV, Yeung HW, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1001\u201330.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"968_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","volume":"156","author":"A Hebert","year":"2020","unstructured":"Hebert A, Thiboutot D, Gold LS, et al. Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne two phase 3 randomized clinical trials. JAMA Dermatol. 2020;156(6):621\u201330.","journal-title":"JAMA Dermatol"},{"issue":"10","key":"968_CR14","first-page":"CD014918","volume":"2024","author":"Y Yuan","year":"2024","unstructured":"Yuan Y, Wang YY, Xia J et al. Topical, light-based, and complementary interventions for acne: an overview of systematic reviews. Cochrane Database Syst Rev. 2024; 2014(10):CD014918.","journal-title":"Cochrane Database Syst Rev"},{"key":"968_CR15","doi-asserted-by":"publisher","first-page":"1349636","DOI":"10.3389\/fimmu.2024.1349636","volume":"15","author":"LQ Ding","year":"2024","unstructured":"Ding LQ, Chen CQ, Yang YK, et al. Major cardiovascular events under biologic psoriasis therapies: a 19-year real-world analysis of FAERS data. Front Immunol. 2024;15:1349636.","journal-title":"Front Immunol"},{"issue":"1","key":"968_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13058-025-02013-w","volume":"27","author":"JM Han","year":"2025","unstructured":"Han JM, Zhai XH, Tao XF, et al. Pharmacovigilance study of adverse reactions of anti-HER-2 drugs for the treatment of HER-2-positive breast cancer based on the FAERS database. Breast Cancer Res. 2025;27(1):54.","journal-title":"Breast Cancer Res"},{"issue":"5","key":"968_CR17","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/bib\/bbx010","volume":"19","author":"S Vilar","year":"2018","unstructured":"Vilar S, Friedman C, Hripcsak G. Detection of drug-drug interactions through data mining studies using clinical sources, scientific literature and social media. Brief Bioinform. 2018;19(5):863\u201377.","journal-title":"Brief Bioinform"},{"key":"968_CR18","doi-asserted-by":"publisher","first-page":"1231320","DOI":"10.3389\/fphar.2023.1231320","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang L, Mao W, Liu D, et al. Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS). Front Pharmacol. 2023;14:1231320.","journal-title":"Front Pharmacol"},{"issue":"1","key":"968_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1021\/acsptsci.3c00116","volume":"7","author":"M Courchesne","year":"2023","unstructured":"Courchesne M, Manrique G, Bernier L, et al. Gender differences in pharmacokinetics: a perspective on contrast agents. ACS Pharmacol Transl Sci. 2023;7(1):8\u201317.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"968_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/vaccines11010044","volume":"11","author":"RI Nassar","year":"2023","unstructured":"Nassar RI, Barakat M, Thiab S, et al. Web-Based reporting of post-vaccination symptoms for inactivated COVID-19 vaccines in Jordan: a cross-sectional study. Vaccines. 2023;11(1):44.","journal-title":"Vaccines"},{"key":"968_CR21","doi-asserted-by":"publisher","first-page":"100188","DOI":"10.1016\/j.eclinm.2019.10.001","volume":"17","author":"S Watson","year":"2019","unstructured":"Watson S, Caster O, Rochon PA, et al. Reported adverse drug reactions in women and men: aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine. 2019;17:100188.","journal-title":"EClinicalMedicine"},{"issue":"42","key":"968_CR22","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.15585\/mmwr.mm7042a3","volume":"70","author":"EF Blau","year":"2021","unstructured":"Blau EF, Flinchum A, Gaub KL, et al. Mycobacterium porcinum skin and soft tissue infections after vaccinations - Indiana, Kentucky, and Ohio, September 2018-February 2019. MMWR Morb Mortal Wkly Rep. 2021;70(42):1472\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"968_CR23","first-page":"CD012594","volume":"10","author":"G Shalviri","year":"2024","unstructured":"Shalviri G, Mohebbi N, Mirbaha F, et al. Improving adverse drug event reporting by healthcare professionals. Cochrane Database Syst Rev. 2024;10:CD012594.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"968_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2471\/BLT.19.232785","volume":"98","author":"S Shukla","year":"2020","unstructured":"Shukla S, Gupta M, Pandit S, et al. Implementation of adverse event reporting for medical devices, India. Bull World Health Organ. 2020;98(3):206\u201311.","journal-title":"Bull World Health Organ"},{"issue":"12","key":"968_CR25","doi-asserted-by":"publisher","first-page":"e203215","DOI":"10.1001\/jamapediatrics.2020.3215","volume":"174","author":"A Khan","year":"2020","unstructured":"Khan A, Yin HS, Brach C, et al. Association between parent comfort with english and adverse events among hospitalized children. JAMA Pediatr. 2020;174(12):e203215\u2013203215.","journal-title":"JAMA Pediatr"},{"issue":"1","key":"968_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/CIRCOUTCOMES.120.007480","volume":"14","author":"J Moon","year":"2021","unstructured":"Moon J, Sedgh RC, Jackevicius CA. Examining the nocebo effect of statins through statin adverse events reported in the food and drug administration adverse event reporting system. Circ Cardiovasc Qual Outcomes. 2021;14(1):28\u201337.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"968_CR27","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2196\/publichealth.9282","volume":"4","author":"CM Hohl","year":"2018","unstructured":"Hohl CM, Small SS, Peddie D, et al. Why clinicians don\u2019t report adverse drug events: qualitative study. JMIR Public Health Surveill. 2018;4(1):214\u201324.","journal-title":"JMIR Public Health Surveill"},{"issue":"2","key":"968_CR28","doi-asserted-by":"publisher","first-page":"e70039","DOI":"10.1111\/jebm.70039","volume":"18","author":"Q Kang","year":"2025","unstructured":"Kang Q, Yau YK, Hu ZR, et al. The indirect impact of COVID-19 pandemic on mortality, complications, and healthcare utilization among patients with chronic respiratory diseases in Hong Kong: an interrupted time series analysis. J Evid Based Med. 2025;18(2):e70039.","journal-title":"J Evid Based Med"},{"issue":"7","key":"968_CR29","doi-asserted-by":"publisher","first-page":"100108","DOI":"10.1016\/j.patter.2020.100108","volume":"1","author":"P Chandak","year":"2020","unstructured":"Chandak P, Tatonetti NP. Using machine learning to identify adverse drug effects posing increased risk to women. Patterns (N Y). 2020;1(7):100108.","journal-title":"Patterns (N Y)"},{"issue":"1","key":"968_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/14760584.2023.2292203","volume":"23","author":"YM Li","year":"2024","unstructured":"Li YM, Lundin SK, Li JF, et al. Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data. Expert Rev Vaccines. 2024;23(1):53\u20139.","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"968_CR31","doi-asserted-by":"publisher","first-page":"e1004024","DOI":"10.1371\/journal.pmed.1004024","volume":"19","author":"S Takuva","year":"2022","unstructured":"Takuva S, Takalani A, Seocharan I, et al. Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial. PLoS Med. 2022;19(6):e1004024.","journal-title":"PLoS Med"},{"issue":"2","key":"968_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s40257-023-00840-1","volume":"25","author":"W Hu","year":"2024","unstructured":"Hu W, Thornton M, Livingston RA. Real-world use of ruxolitinib cream: safety analysis at 1 year. Am J Clin Dermatol. 2024;25(2):327\u201332.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"968_CR33","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jaci.2017.01.027","volume":"140","author":"E Guttman-Yassky","year":"2017","unstructured":"Guttman-Yassky E, Ungar B, Malik K, et al. Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis. J Allergy Clin Immunol. 2017;140(4):1032\u201342.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"968_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0729-3","volume":"7","author":"S Thapi","year":"2019","unstructured":"Thapi S, Leiter A, Galsky M, et al. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis. J Immunother Cancer. 2019;7(1):1\u20135.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"968_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/humrep\/deaa313","volume":"36","author":"J Kim","year":"2021","unstructured":"Kim J, Whitcomb BW, Kwan B, et al. Psychosocial stress and ovarian function in adolescent and young adult cancer survivors. Hum Reprod. 2021;36(2):405\u201314.","journal-title":"Hum Reprod"},{"issue":"18","key":"968_CR36","doi-asserted-by":"publisher","first-page":"8558","DOI":"10.1039\/D3FO03153E","volume":"14","author":"M Akram","year":"2023","unstructured":"Akram M, Ali SA, Kaul G. Probiotic and prebiotic supplementation ameliorates chronic restraint stress-induced male reproductive dysfunction. Food Funct. 2023;14(18):8558\u201374.","journal-title":"Food Funct"},{"issue":"8","key":"968_CR37","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/j.jid.2024.01.027","volume":"144","author":"HJ Pyle","year":"2024","unstructured":"Pyle HJ, Evans JC, Artami M, et al. Assessment of the cutaneous hormone landscapes and microbiomes in vulvar lichen sclerosus. J Invest Dermatol. 2024;144(8):1808\u201316.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"968_CR38","doi-asserted-by":"publisher","first-page":"101291","DOI":"10.1016\/j.beem.2019.101291","volume":"33","author":"C Wei","year":"2019","unstructured":"Wei C, Crowne E. The impact of childhood cancer and its treatment on puberty and subsequent hypothalamic pituitary and gonadal function, in both boys and girls. Best Pract Res Clin Endocrinol Metab. 2019;33(3):101291.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"968_CR39","doi-asserted-by":"publisher","first-page":"101112","DOI":"10.1016\/j.molmet.2020.101112","volume":"43","author":"M Werdermann","year":"2021","unstructured":"Werdermann M, Berger I, Scriba LD, et al. Insulin and obesity transform hypothalamic-pituitary-adrenal axis stemness and function in a hyperactive state. Mol Metab. 2021;43:101112.","journal-title":"Mol Metab"},{"issue":"12","key":"968_CR40","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.jid.2016.07.018","volume":"136","author":"J Boix","year":"2016","unstructured":"Boix J, Sevilla LM, S\u00e1ez Z, et al. Epidermal mineralocorticoid receptor plays beneficial and adverse effects in skin and mediates glucocorticoid responses. J Invest Dermatol. 2016;136(12):2417\u201326.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"968_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12016-018-8705-0","volume":"56","author":"HL Nguyen","year":"2019","unstructured":"Nguyen HL, Yiannias JA. Contact dermatitis to medications and skin products. Clin Rev Allergy Immunol. 2019;56(1):41\u201359.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"968_CR42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12519-016-0018-x","volume":"12","author":"A U\u00e7ar","year":"2016","unstructured":"U\u00e7ar A, Bas F, Saka N. Diagnosis and management of pediatric adrenal insufficiency. World J Pediatr. 2016;12(3):261\u201374.","journal-title":"World J Pediatr"},{"key":"968_CR43","doi-asserted-by":"publisher","first-page":"112071","DOI":"10.1016\/j.bios.2020.112071","volume":"154","author":"SH Lee","year":"2020","unstructured":"Lee SH, Lee M, Yang H, et al. Bioelectronic sensor mimicking the human neuroendocrine system for the detection of hypothalamic-pituitary-adrenal axis hormones in human blood. Biosens Bioelectron. 2020;154:112071.","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"968_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13311-017-0600-5","volume":"15","author":"A Farzi","year":"2018","unstructured":"Farzi A, Fr\u00f6hlich EE, Holzer P. Gut microbiota and the neuroendocrine system. Neurotherapeutics. 2018;15(1):5\u201322.","journal-title":"Neurotherapeutics"},{"key":"968_CR45","doi-asserted-by":"publisher","first-page":"1342833","DOI":"10.3389\/fimmu.2024.1342833","volume":"15","author":"L Goudman","year":"2024","unstructured":"Goudman L, Demuyser T, Pilitsis JG, et al. Gut dysbiosis in patients with chronic pain: a systematic review and meta-analysis. Front Immunol. 2024;15:1342833.","journal-title":"Front Immunol"},{"issue":"2","key":"968_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5582\/bst.2022.01115","volume":"16","author":"K Sato","year":"2022","unstructured":"Sato K, Niimi Y, Mano T, et al. Time to onset of drug-induced parkinsonism: analysis using a large Japanese adverse event self-reporting database. Biosci Trends. 2022;16(2):151\u20137.","journal-title":"Biosci Trends"},{"key":"968_CR47","doi-asserted-by":"publisher","first-page":"1397692","DOI":"10.3389\/fimmu.2024.1397692","volume":"15","author":"MM Yu","year":"2024","unstructured":"Yu MM, Zhou LJ, Cao MD, et al. Post-marketing drug safety surveillance of enfortumab vedotin: an observational pharmacovigilance study based on a real-world database. Front Immunol. 2024;15:1397692.","journal-title":"Front Immunol"},{"issue":"5","key":"968_CR48","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.bja.2024.10.013","volume":"134","author":"HQ Huang","year":"2025","unstructured":"Huang HQ, Hu CW, Liu F, et al. Glucagon-like peptide-1 receptor agonists and impaired gastric emptying: a pharmacovigilance analysis of the US food and drug administration adverse event reporting system. Br J Anaesth. 2025;134(5):1486\u201396.","journal-title":"Br J Anaesth"},{"issue":"1","key":"968_CR49","doi-asserted-by":"publisher","first-page":"e000371","DOI":"10.1136\/jitc-2019-000371","volume":"8","author":"PV Nuzzo","year":"2020","unstructured":"Nuzzo PV, Pond GR, Abou Alaiwi S, et al. Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors. J Immunother Cancer. 2020;8(1):e000371.","journal-title":"J Immunother Cancer"},{"issue":"8","key":"968_CR50","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","volume":"17","author":"D Dearnaley","year":"2016","unstructured":"Dearnaley D, Syndikus I, Mossop H, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol. 2016;17(8):1047\u201360.","journal-title":"Lancet Oncol"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-00968-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-00968-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-00968-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:01:45Z","timestamp":1783695705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-026-00968-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["968"],"URL":"https:\/\/doi.org\/10.1007\/s43441-026-00968-2","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No ethical approval was sought or required because the analysis involved only de-identified data obtained from public sources.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}